European Companies Search Engine
EU funding (€3,939,918): Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy Hor3 Jul 2020 EU Research and Innovation programme "Horizon"
Overview
Text
Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy
The European Training Network PHAST (Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy) provides excellent, highly-skilled education and training in the vibrant field of Biophotonics for 15 Early Stage Researchers (ESRs) in a strong multidisciplinary PhD programme. PHAST addresses some relevant “unmet needs” of the medical community in prevention, diagnosis and treatment of cancer – one of the leading causes of death worldwide – to significantly improve the quality of life for European society. The main scientific goal of PHAST is to develop multiscale advanced photonic technologies for the diagnosis of cancer in vitro and in vivo and the monitoring of therapy for personalized medicine, through its four specific objectives: 1. In-vitro diagnosis as point-of-care approach through optical spectroscopy combined with innovative sampling techniques. 2. Tissue diagnostics and functional monitoring by optical fibre-based biopsy and diffuse optical spectroscopy. 3. Microscale cancer monitoring by multimodal optical imaging of tumour borders during surgery. 4. Macroscale therapy monitoring by diffuse optical spectroscopy, multifunctional optical fibre sensors, autofluorescence, and hyperspectral imaging. The multi-scale level approach employed by PHAST will allow early cancer detection from molecular disease markers in body-liquids up to live organs. In specific cases these techniques will be validated in the clinic thanks to close collaboration with medical institutions. The ESRs will be trained to all the technologies through hands-on laboratory platforms, thematic workshops and courses to build solid careers as biophotonics professionals in both academic and non-academic sectors. This will be possible thanks to the multidisciplinary environment created by the PHAST consortium, composed of research institutions, 2 hospitals and 8 industries, among them specialized small companies as well as global players in the field such as Horiba, Philips and Zeiss.
Funded Companies:
| Company name | Funding amount |
| Albert-Ludwigs-Universitaet Freiburg | €252,788 |
| Fondazione Links - Leading Innovation & Knowledge FOR Society | €261,500 |
| Friedrich-Schiller-Universität Jena | €252,788 |
| Fundacio Institut de Ciencies Fotoniques | €250,905 |
| Grintech GmbH | €252,788 |
| Horiba France SAS | €274,802 |
| Leibniz-Institut Fuer Photonische Technologien e. V. | €252,788 |
| Medizinische Universitaet Wien | €264,207 |
| Ospedale SAN Raffaele Srl | €261,500 |
| Politecnico Di Milano | €261,500 |
| Politecnico Di Torino | €261,500 |
| Spectracure AB | €281,983 |
| Universita Degli Studi Di Parma | €261,500 |
| University College Cork - National University of Ireland, Cork | €549,369 |
Source: https://cordis.europa.eu/project/id/860185
The filing refers to a past date, and does not necessarily reflect the current state.
